Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Cash Flow Quality Index
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Cash Flow Quality Index of 17.35x as of September 2025. Operating cash flow of CN¥90.75 Million exceeds net income of CN¥5.23 Million, indicating high earnings quality where cash backs reported profits. Explore Luoxin Pharmaceuticals Group Stock Co Lt cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luoxin Pharmaceuticals Group Stock Co Ltd Cash Flow Quality Index (2011–2021)
Historical Cash Flow Quality Index for Luoxin Pharmaceuticals Group Stock Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Luoxin Pharmaceuticals Group Stock Co Lt reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2021)
Year-by-year earnings quality comparison for Luoxin Pharmaceuticals Group Stock Co Ltd. For live market cap and the full company financial profile, see 002793 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.29x | CN¥120.63 Million | CN¥421.65 Million | ▲ +402.5% |
| 2020 | -0.09x | CN¥-32.40 Million | CN¥342.60 Million | ▼ -153.1% |
| 2019 | 0.18x | CN¥116.33 Million | CN¥653.76 Million | ▼ -82.6% |
| 2018 | 1.02x | CN¥114.12 Million | CN¥111.35 Million | ▲ +16.1% |
| 2017 | 0.88x | CN¥102.27 Million | CN¥115.85 Million | ▲ +21.8% |
| 2016 | 0.72x | CN¥72.74 Million | CN¥100.36 Million | ▲ +2.0% |
| 2015 | 0.71x | CN¥58.12 Million | CN¥81.79 Million | ▲ +8.7% |
| 2014 | 0.65x | CN¥41.83 Million | CN¥63.96 Million | ▼ -53.6% |
| 2013 | 1.41x | CN¥64.75 Million | CN¥45.96 Million | ▲ +126.9% |
| 2012 | 0.62x | CN¥33.31 Million | CN¥53.67 Million | ▼ -56.6% |
| 2011 | 1.43x | CN¥46.53 Million | CN¥32.52 Million | — |